Workflow
Earnings estimate revisions
icon
Search documents
Waters (WAT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
ZACKS· 2026-02-27 15:55
Core Viewpoint - The stock price of Waters (WAT) has been on a bearish trend, losing 14% over the past four weeks, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be increasing [1][2]. Technical Analysis - The hammer chart pattern indicates a possible bottoming out, with reduced selling pressure, suggesting that bulls may be gaining control [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, indicating that after a new low, buying interest emerges to push the stock price up [4][5]. - This pattern can occur across various timeframes and is utilized by both short-term and long-term investors [5]. Fundamental Analysis - There is a strong consensus among Wall Street analysts to raise earnings estimates for WAT, which supports the bullish case for the stock [2][7]. - Over the last 30 days, the consensus EPS estimate for the current year has increased by 1.1%, indicating that analysts expect better earnings than previously predicted [8]. - WAT currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10]. Conclusion - The combination of the hammer chart pattern and positive earnings estimate revisions enhances the likelihood of a trend reversal for WAT, making it a stock to watch for potential investment opportunities [1][7][10].
Does Nuvalent (NUVL) Have the Potential to Rally 37.26% as Wall Street Analysts Expect?
ZACKS· 2026-02-27 15:55
Nuvalent, Inc. (NUVL) closed the last trading session at $103.93, gaining 1.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $142.65 indicates a 37.3% upside potential.The mean estimate comprises 17 short-term price targets with a standard deviation of $13.19. While the lowest estimate of $125.00 indicates a 20.3% increase from the current price level, the most optimistic analyst ...
Does Inventiva (IVA) Have the Potential to Rally 136.34% as Wall Street Analysts Expect?
ZACKS· 2026-02-27 15:55
Shares of Inventiva S.A. Sponsored ADR (IVA) have gained 3.6% over the past four weeks to close the last trading session at $6.55, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15.48 indicates a potential upside of 136.3%.The mean estimate comprises 12 short-term price targets with a standard deviation of $5.56. While the lowest estimate of $8.80 indicates a 34.4% increase fr ...
Wall Street Analysts Believe LendingClub (LC) Could Rally 39.35%: Here's is How to Trade
ZACKS· 2026-02-27 15:55
Shares of LendingClub (LC) have gained 1.7% over the past four weeks to close the last trading session at $16.72, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $23.3 indicates a potential upside of 39.4%.The mean estimate comprises 10 short-term price targets with a standard deviation of $1.95. While the lowest estimate of $20.00 indicates a 19.6% increase from the current pri ...
Wall Street Analysts Believe Auna S.A. (AUNA) Could Rally 29.32%: Here's is How to Trade
ZACKS· 2026-02-27 15:55
Shares of Auna S.A. (AUNA) have gained 9.7% over the past four weeks to close the last trading session at $5.32, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $6.88 indicates a potential upside of 29.3%.The average comprises five short-term price targets ranging from a low of $6.00 to a high of $9.00, with a standard deviation of $1.24. While the lowest estimate indicates an i ...
Wall Street Analysts Think Carriage Services (CSV) Could Surge 33.33%: Read This Before Placing a Bet
ZACKS· 2026-02-27 15:55
Carriage Services (CSV) closed the last trading session at $45.19, gaining 6.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $60.25 indicates a 33.3% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $3.69. While the lowest estimate of $56.00 indicates a 23.9% increase from the current price level, the most optimistic analyst ...
Globalstar (GSAT) Reports Q4 Loss, Tops Revenue Estimates
ZACKS· 2026-02-27 15:35
Core Viewpoint - Globalstar reported a quarterly loss of $0.07 per share, significantly worse than the Zacks Consensus Estimate of $0.01, marking an earnings surprise of -1,500.00% [1] Financial Performance - The company posted revenues of $71.96 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 0.23% and up from $61.18 million a year ago [2] - Over the last four quarters, Globalstar has surpassed consensus EPS estimates two times and topped revenue estimates three times [2] Stock Performance - Globalstar shares have declined approximately 5.2% since the beginning of the year, while the S&P 500 has gained 0.9% [3] - The current Zacks Rank for Globalstar is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $76.53 million, and for the current fiscal year, it is $0.14 on revenues of $311.65 million [7] - The trend of earnings estimate revisions for Globalstar was mixed ahead of the earnings release, which could change following the recent report [6] Industry Context - The Satellite and Communication industry, to which Globalstar belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Globalstar's stock performance [5]
Tree.com (TREE) Soars 8.0%: Is Further Upside Left in the Stock?
ZACKS· 2026-02-27 15:01
Tree.com (TREE) shares rallied 8% in the last trading session to close at $38.32. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 38.7% loss over the past four weeks.The company’s shares moved sharply higher after it completed a 1-for-10 reverse stock split aimed at improving listing compliance and enhancing its appeal to institutional investors. The move comes as TREE continues to reposition its marketplace ...
1stdibs.com (DIBS) Reports Q4 Loss, Lags Revenue Estimates
ZACKS· 2026-02-27 14:11
1stdibs.com (DIBS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +25.00%. A quarter ago, it was expected that this upscale online retailer would post a loss of $0.13 per share when it actually produced a loss of $0.1, delivering a surprise of +23.08%.Over the last four quarters, the compa ...
ANI Pharmaceuticals (ANIP) Surpasses Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-27 14:05
分组1 - ANI Pharmaceuticals reported quarterly earnings of $2.33 per share, exceeding the Zacks Consensus Estimate of $1.99 per share, and showing an increase from $1.63 per share a year ago, resulting in an earnings surprise of +17.32% [1] - The company achieved revenues of $247.06 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 6.04% and increasing from $190.57 million year-over-year [2] - ANI has consistently surpassed consensus EPS estimates for the last four quarters, indicating strong performance [2] 分组2 - The stock has underperformed the market with a decline of about 2.3% since the beginning of the year, while the S&P 500 has gained 0.9% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is $1.33 on revenues of $200.02 million, and for the current fiscal year, it is $8.22 on revenues of $1.07 billion [7] 分组3 - The Medical - Biomedical and Genetics industry, to which ANI belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for ANI was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6]